Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1996 1
1997 2
1998 4
1999 4
2000 3
2001 7
2002 4
2003 18
2004 8
2005 12
2006 16
2007 20
2008 22
2009 25
2010 32
2011 27
2012 37
2013 33
2014 39
2015 43
2016 42
2017 39
2018 26
2019 19
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

436 results
Results by year
Filters applied: . Clear all
Page 1
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
Amin AR, Khuri FR, Chen ZG, Shin DM. Amin AR, et al. Cancer Prev Res (Phila). 2009 Jun;2(6):538-45. doi: 10.1158/1940-6207.CAPR-09-0063. Epub 2009 May 26. Cancer Prev Res (Phila). 2009. PMID: 19470788 Free PMC article.
The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells.
Milligan SA, Burke P, Coleman DT, Bigelow RL, Steffan JJ, Carroll JL, Williams BJ, Cardelli JA. Milligan SA, et al. Clin Cancer Res. 2009 Aug 1;15(15):4885-94. doi: 10.1158/1078-0432.CCR-09-0109. Epub 2009 Jul 28. Clin Cancer Res. 2009. PMID: 19638461 Free PMC article.
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR, Müller S, Lewis M, Sica G, Kono S, Brandes JC, Grist WJ, Moreno-Williams R, Beitler JJ, Thomas SM, Chen Z, Shin HJ, Grandis JR, Khuri FR, Chen ZG. Shin DM, et al. Clin Cancer Res. 2013 Mar 1;19(5):1244-56. doi: 10.1158/1078-0432.CCR-12-3149. Epub 2013 Feb 19. Clin Cancer Res. 2013. PMID: 23422093 Free PMC article. Clinical Trial.
Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Leeman-Neill RJ, et al. Clin Cancer Res. 2010 May 1;16(9):2571-9. doi: 10.1158/1078-0432.CCR-10-0333. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388852 Free PMC article.
Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS. Chang CM, et al. Oncol Rep. 2012 Nov;28(5):1799-807. doi: 10.3892/or.2012.1991. Epub 2012 Aug 24. Oncol Rep. 2012. PMID: 22923287
436 results
Jump to page
Feedback